Significance of Infections in Implant Loss After Breast Reconstruction in the Course of Breast Cancer Treatment

Publications

Share / Export Citation / Email / Print / Text size:

Polish Journal of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 1733-1331
eISSN: 2544-4646

DESCRIPTION

0
Reader(s)
0
Visit(s)

Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 68 , ISSUE 4 (Jan 2019) > List of articles

Significance of Infections in Implant Loss After Breast Reconstruction in the Course of Breast Cancer Treatment

MARIA SZYMANKIEWICZ * / TOMASZ NOWIKIEWICZ / MARTA BIEDKA

Keywords : breast cancer, implants, infections, etiological agents

Citation Information : Polish Journal of Microbiology. Volume 68, Issue 4, Pages 343-351, DOI: https://doi.org/10.33073/pjm-2019-037

License : (CC-BY-4.0)

Published Online: 03-September-2019

ARTICLE

ABSTRACT

Content not available Share

FIGURES & TABLES

REFERENCES

  1. Abedi N, Ho AL, Knox A, Tashakkor Y, Omeis T, Van Laeken N, Lennox P, Macadam SA. Predictors of mastectomy flap necrosis in patients undergoing immediate breast reconstruction: a review of 718 patients. Ann Plast Surg. 2016;76(6):629–634. https://doi.org/10.1097/SAP.0000000000000262
    [PUBMED] [CROSSREF]
  2. Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the Women’s Health and Cancer Rights Act. JAMA. 2006;295(4):383–388. https://doi.org/10.1001/jama.295.4.387
  3. Al-Halabi B, Viezel-Mathieu A, Shulman Z, Behr MA, Fouda Neel O. Plast Reconstr Surg. 2018;142(5):639e–652e. https://doi.org/10.1097/PRS.0000000000004892
    [PUBMED] [CROSSREF]
  4. Araco A, Gravante G, Araco F, Delogu D, Cervelli V, Walgenbach K. A retrospective analysis of 3,000 primary aesthetic breast augmentations: postoperative complications and associated factors. Aesthetic Plast Surg. 2007;31(5):532–539. https://doi.org/10.1007/s00266-007-0162-8
    [PUBMED] [CROSSREF]
  5. Blough JT, Vu MM, Qiu CS, Mlodinow AS, Khavanin N, Fine NA, Kim JYS. Beyond 30 days: a risk calculator for longer term outcomes of prosthetic breast reconstruction. Plast Reconstr Surg Glob Open. 2018;6(12):e2065. https://doi.org/10.1097/GOX.0000000000002065
    [PUBMED] [CROSSREF]
  6. Bocian A, Kurczych K, Maliszewski D. Postępowanie rekonstrukcyjne u chorych na raka piersi – wskazania szczegółowe. In: Nowecki ZI, Jeziorski A, editors. Chirurgiczne leczenie zmian nowotworowych piersi (Reconstruction procedures in patients with breast cancer-detailed indications. In: Surgical treatment of breast cancer). Konsensus Polskiego Towarzystwa Chirurgii Onkologicznej (Consensus of the Polish Society of Oncological Surgery). Gdańsk (Poland): Via Medica; 2016. p. 78–80.
  7. Brand KG. Infection of mammary prostheses: a survey and the question of prevention. Ann Plast Surg. 1993;30(4):289–295. https://doi.org/10.1097/00000637-199304000-00001
    [PUBMED] [CROSSREF]
  8. Chattha AS, Cohen JB, Bucknor A, Chen AD, Tobias AM, Lee BT, Lin SJ. Surgical site infection in immediate breast reconstruction: does chemotherapy timing make a difference? J Surg Oncol. 2018;117(7):1440–1446. https://doi.org/10.1002/jso.25053
    [PUBMED] [CROSSREF]
  9. Chessa D, Ganau G, Spiga L, Bulla A, Mazzarello V, Campus GV, Rubino S. Staphylococcus aureus and Staphylococcus epidermidis virulence strains as causative agents of persistent infections in breast implants. PLoS One. 2016;11(1):e0146668. https://doi.org/10.1371/journal.pone.0146668
    [PUBMED] [CROSSREF]
  10. Chidester JR, Danci I, Lewis P, Biskup N, Kim H, Gupta S. Antibiogram for periprosthetic infections. A tool for better informed selection of empiric antibiotics for surgical site infections. Ann Plast Surg. 2016;76 Suppl 3:S158–S161. https://doi.org/10.1097/SAP.0000000000000803
    [PUBMED] [CROSSREF]
  11. Conte MP, Superti F, Moio M, Ammendolia MG, Longhi C, Aleandri M, Marazzato M, Goldoni P, Parisi P, Borab Z, et al. Bacterial biofilm associated with a case of capsular contracture. New Microbiol. 2018;41(3):238–241.
    [PUBMED]
  12. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. https://doi.org/10.1126/science.284.5418.1318
    [PUBMED] [CROSSREF]
  13. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2): 67–193. https://doi.org/10.1128/CMR.15.2.167-193.2002
    [CROSSREF]
  14. Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010;126(3):779–785. https://doi.org/10.1097/PRS.0b013e3181e5f7ff
    [PUBMED] [CROSSREF]
  15. Fleischer M, Ozorowski T, Pawlik K, Skoczyńska A, Dubiel G, Mączyńska A, Żabicka D, Hryniewicz W. Zalecenia prowadzenia mikrobiologicznych badań przesiewowych u hospitalizowanych pacjentów. Narodowy Program Ochrony Antybiotyków na lata 2016–2020 [Internet]. Warszawa (Poland): Narodowy Instytut Leków; 2017 [cited 2018 Apr 10]. Available from http://antybiotyki.edu.pl/wp-content/uploads/2017/10/ZALECENIAPROWADZENI-ABADAN13.07.pdf
  16. Halvorson EG, Disa JJ, Mehrara BJ, Burkey BA, Pusic AL, Cordeiro PG. Outcome following removal of infected tissue expanders in breast reconstruction: a 10-year experience. Ann Plast Surg. 2007; 59(2): 131–136. https://doi.org/10.1097/01.sap.0000252716.73356.68
    [PUBMED] [CROSSREF]
  17. Ilonzo N, Tsang A, Tsantes S, Estabrook A, Thu Ma AM. Breast reconstruction after mastectomy: a ten-year analysis of trends and immediate postoperative outcomes. Breast. 2017;32:7–12. https://doi.org/10.1016/j.breast.2016.11.023
    [PUBMED] [CROSSREF]
  18. Isenberg HD. Clinical Microbiology Procedures Handbook. Washington D.C. (USA): ASM Press; 2004.
  19. Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Pierce LJ, Kronowitz SJ, Smith BD. Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis. Ann Surg. 2016;263(2):219–227. https://doi.org/10.1097/SLA.0000000000001177
    [PUBMED] [CROSSREF]
  20. Lankiewicz JD, Yokoe DS, Olsen MA, Onufrak F, Fraser VJ, Stevenson K, Khan Y, Hooper D, Platt R, Huang SS. Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? Infect Control Hosp Epidemiol. 2012;33(2):202–204. https://doi.org/10.1086/663715
    [PUBMED] [CROSSREF]
  21. McCullough MC, Chu CK, Duggal CS, Losken A, Carlson GW. Antibiotic prophylaxis and resistance in surgical site infection after immediate tissue expander reconstruction of the breast. Ann Plast Surg. 2016;77(5):501–505. https://doi.org/10.1097/SAP.0000000000000275
    [PUBMED] [CROSSREF]
  22. Momoh AO, Ahmed R, Kelley BP, Aliu O, Kidwell KM, Kozlow JH, Chung KC. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postre-construction radiotherapy. Ann Surg Oncol. 2014;21(1):118–124. https://doi.org/10.1245/s10434-013-3284-z
    [PUBMED] [CROSSREF]
  23. NCIN. Breast cancer. The second all breast cancer report. Surgical treatment outcomes and The non-invasive breast cancer report [Internet]. London (UK): National Cancer Intelligence Network; 2011 [cited 2018 Apr 10]. Available from http://www.ncin.org.uk/cancer_type_and_topic_specific_work/cancer_type_specific_work/breast_cancer/
  24. Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Wallace AE, Fraser VJ. Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures. JAMA Surg. 2017;152(9):e172338. https://doi.org/10.1001/jamasurg.2017.2338
    [PUBMED] [CROSSREF]
  25. Olsen MA, Nickel KB, Fox IK. Surveillance and prevention of surgical site infections in breast oncologic surgery with immediate reconstruction. Curr Treat Options Infect Dis. 2017;9(2):155–172. https://doi.org/10.1007/s40506-017-0117-9
    [PUBMED] [CROSSREF]
  26. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111(5):1605–1611. https://doi.org/10.1097/01.PRS.0000054768.14922.44
    [PUBMED] [CROSSREF]
  27. Phillips BT, Bishawi M, Dagum AB, Khan SU, Bui DT. A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence? Plast Reconstr Surg. 2013;131(1):1–13. https://doi.org/10.1097/PRS.0b013e3182729c39
    [PUBMED] [CROSSREF]
  28. Phillips BT, Halvorson EG. Antibiotic prohylaxis following implant-based breast reconstruction: what is the evidence? Plast Reconstr Surg. 2016;138(4):751–757. https://doi.org/10.1097/PRS.0000000000002530
    [PUBMED] [CROSSREF]
  29. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis. 2005;5(2):94–106. https://doi.org/10.1016/S1473-3099(05)70084-0
    [PUBMED] [CROSSREF]
  30. Prażmo E, Godlewska R, Kwaśny M, Mielczarek A. Virulence factors of Enterococcus faecalis in relation to pulp diseases and periapical infections. Postepy Mikrobiol. 2016;55:247–254.
  31. Romero FA, Powell EA, Babady NE, Kaltsas A, Figueroa CJ, Pulitzer M, Mehrara BJ, Glickman MS, Morjaria S. Nontuberculous mycobacterial infections after silicone breast implant reconstruction emphasize a diversity of infecting mycobacteria. Open Forum Infect Dis. 2017;4(4):ofx189. https://doi.org/10.1093/ofid/ofx189
    [PUBMED] [CROSSREF]
  32. Seng P, Bayle S, Alliez A, Romain F, Casanova D, Stein A. The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the south of France. Int J Infect Dis. 2015;35:62–66. https://doi.org/10.1016/j.ijid.2015.04.010
    [PUBMED] [CROSSREF]
  33. Sinha I, Pusic AL, Wilkins EG, Hamill JB, Chen X, Kim HM, Guldbrandsen G, Chun YS. Late surgical-site infection in immediate implant-based breast reconstruction. Plast Reconstr Surg. 2017;139(1):20–28. https://doi.org/10.1097/PRS.0000000000002839
    [PUBMED] [CROSSREF]
  34. Song JH, Kim YS, Jung BK, Lee DW, Song SY, Roh TS, Lew DH. Salvage of infected breast implants. Arch Plast Surg. 2017;44(6):516–522. https://doi.org/10.5999/aps.2017.01025
    [PUBMED] [CROSSREF]
  35. Tarkowski R, Szmigiel K, Rubin A, Borowiec G, Szelachowska J, Jagodziński W, Bębenek M. Patient’s education before mastectomy influences the rate of reconstructive surgery. J Cancer Educ. 2017;32(3):537–542. https://doi.org/10.1007/s13187-016-0982-9
    [PUBMED] [CROSSREF]
  36. Vacheethasanee K, Temenoff JS, Higashi JM, Gary A, Anderson JM, Bayston R, Marchant RE. Bacterial surface properties of clinically isolated Staphylococcus epidermidis strains determine adhesion on polyethylene. J Biomed Mater Res. 1998;42(3):425–432. https://doi.org/10.1002/(SICI)1097-4636(19981205)42:3<425::AIDJBM12>3.0.CO;2-F
    [PUBMED] [CROSSREF]
  37. Viola GM, Baumann DP, Mohan K, Selber J, Garvey P, Reece G, Raad II, Rolston KV, Crosby MA. Improving antimicrobial regimens for the treatment of breast tissue expander-related infections. Plast Reconstr Surg Glob Open. 2016;4(5):e704. https://doi.org/10.1097/GOX.0000000000000690
    [PUBMED] [CROSSREF]
  38. Warren Peled A, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, Alvarado M, Esserman LJ, Hwang ES. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg. 2010;145(9):880–885. https://doi.org/10.1001/archsurg.2010.163
    [PUBMED] [CROSSREF]
  39. Weichman KE, Levine SM, Wilson SC, Choi M, Karp NS. Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction. Ann Plast Surg. 2013;71(2):140–143. https://doi.org/10.1097/SAP.0b013e3182590924
    [PUBMED] [CROSSREF]

EXTRA FILES

COMMENTS